APOF and central nervous system cancer: In terms of OS, we found that high-expression APOF was significantly associated with poor prognosis in glioma (GBMLGG), and low-expression APOF was significantly associated with poor prognosis in LIHC and pancreatic adenocarcinoma (PAAD) (Fig. 1B).